9 completed, 1 terminated, 1 withdrawn. 10 Phase 1, 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 10 | Completed 8, Terminated 1, Withdrawn 1 |
| Phase 2 | 3 | Completed 3 |
Follow Ichor Medical Systems Incorporated: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Combinatorial Therapy to Induce an HIV Remission Combination Intervention - HIV/AIDS | Phase 1 / Phase 2 | Completed | University of California, San Francisco | 11 | 2020-08-01 | 2026-08-28 |
| Combination HTNV and PUUV DNA Vaccine Hantaan virus vaccine (HTNV) - Using TriGrid Delivery System (TDS) for Intradermal Delivery (ID), Hantaan virus vaccine (HTNV) - Using TriGrid Delivery System (TDS) for Intramuscular Delivery (IM), Puumala virus vaccine (PUUV) - Using the TriGrid Delivery System (TDS) for Intradermal Delivery (ID) - Hantaan Virus Disease, Puumala Virus | Phase 1 | Completed | U.S. Army Medical Research and Development Command | 61 | 2019-07-10 | 2025-06-26 |
| Phase 2a Immunogenicity Study of Hantaan/Puumala Virus DNA Vaccine for Prevention of Hemorrhagic Fever HTNV/PUUV DNA vaccine, Placebo, TriGrid Delivery System (TDS) - Hemorrhagic Fever With Renal Syndrome | Phase 2 | Completed | U.S. Army Medical Research and Development Command | 130 | 2014-07-09 | 2021-02-12 |
| Safety & Immunogenicity of HIV Vaccines in Healthy Kenyan Adults Ad35-GRIN, MVA.HIVconsv, pSG2.HIVconsv DNA - AIDS | Phase 1 / Phase 2 | Completed | University of Oxford | 72 | 2014-03-01 | 2016-05-30 |
| Study of a DNA-based Venezuelan Equine Encephalitis Virus DNA Vaccine Administered by Electroporation in Healthy Volunteers Venezuelan Equine Encephalitis Virus DNA Vaccine Candidate, 0.9% saline placebo - Venezuelan Equine Encephalitis Virus Infection | Phase 1 | Completed | Ichor Medical Systems Incorporated | 42 | 2013-12-01 | 2015-08-26 |
| Safety Study of HPV DNA Vaccine to Treat Head and Neck Cancer Patients DNA Vaccine, Cyclophosphamide - Head and Neck Cancer | Phase 1 | Terminated | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2 | 2012-04-01 | 2018-11-23 |
| Study to Evaluate the Safety, Tolerability, and Immunogenicity of Hantaan and Puumala Virus DNA Vaccines Vaccine/device combination for prevention of HFRS - Hemorrhagic Fever With Renal Syndrome | Phase 1 | Completed | U.S. Army Medical Research and Development Command | 31 | 2012-01-01 | 2013-01-31 |
| Safety and Immunogenicity Study of HIV-MAG Vaccine +/- IL-12 and Ad35-GRIN/ENV in HIV-uninfected Volunteers HIV-MAG (3,000mcg), GENEVAX® IL-12 (100mcg), GENEVAX® IL-12 (1000mcg) - HIV Infections | Phase 1 | Completed | International AIDS Vaccine Initiative | 75 | 2011-12-01 | 2013-09-02 |
| Study of a Potential Preventive Vaccine Against HIV in Healthy Volunteers TriGrid™ Delivery System, conventional intramuscular injection - HIV Infections | Phase 1 | Completed | Rockefeller University | 40 | 2007-09-01 | 2011-05-05 |
| Safety and Immunogenicity of a Melanoma DNA Vaccine Delivered by Electroporation Xenogeneic Tyrosinase DNA Vaccine, TriGrid Delivery System for Intramuscular Electroporation - Melanoma (Skin), Intraocular Melanoma | Phase 1 | Completed | Ichor Medical Systems Incorporated | 24 | 2007-04-01 | 2011-06-07 |
| Electroporation Therapy With Bleomycin in Treating Patients With Pancreatic Cancer bleomycin sulfate, electroporation therapy - Pancreatic Cancer | Phase 1 | Withdrawn | Ichor Medical Systems Incorporated | 2000-12-01 | 2012-09-19 |
Acquired Immunodeficiency Syndrome (4) · HIV Infections (2) · Hemorrhagic Fever with Renal Syndrome (2) · Encephalomyelitis, Venezuelan Equine (1) · Hantavirus Infections (1) · Head and Neck Neoplasms (1) · Melanoma (1) · Pancreatic Neoplasms (1) · Sexually Transmitted Diseases, Viral (1) · Uveal Melanoma (1)
Bleomycin (1) · Cyclophosphamide (1) · Electroporation Therapies (1) · Vaccines (1) · Vaccines, DNA (1) · detox adjuvant (1) · tyramine-deoxysorbitol (1)
United States (8) · Kenya (2) · Rwanda (1) · Uganda (1)
David Ho, M.D. (1) · James E Moon, MD (1) · Jedd D. Wolchok, MD, PhD (1) · Joseph Califano, MD (1) · Kirsten E Lyke, MD (1) · Kristopher Paolino, MD (1) · Richard C. Karl, MD (1) · Walter Jaoko (1)
PMID 21603651, PMID 24829756, PMID 26252526, PMID 27206386, PMID 32469893, PMID 41326736
P50DE019032 (1), UM1AI164560 (1)